Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer

IMPORTANCE: The 21-gene assay recurrence score is increasingly used to personalize treatment recommendations for systemic therapy in postmenopausal women with estrogen receptor (ER)– or progesterone receptor (PR)–positive, node-positive breast cancer; however, the relevance of the 21-gene assay to r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Woodward, Wendy A., Barlow, William E., Jagsi, Reshma, Buchholz, Thomas A., Shak, Steven, Baehner, Frederick, Whelan, Timothy J., Davidson, Nancy E., Ingle, James N., King, Tari A., Ravdin, Peter M., Osborne, C. Kent, Tripathy, Debasish, Livingston, Robert B., Gralow, Julie R., Hortobagyi, Gabriel N., Hayes, Daniel F., Albain, Kathy S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6990911/
https://ncbi.nlm.nih.gov/pubmed/31917424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.5559
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados